4-Bromo-3,5-bis(3,4-dimethylphenyl)-1H-pyrazole

Catalog No.: 
ACPLCZ058
CAS No.: 
1187632-17-2
Molecular Formula: 
C19H19BrN2
Molecular Weight: 
355.28
4-Bromo-3,5-bis(3,4-dimethylphenyl)-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$104.00InquiryInquiry
100mg97%$148.00InquiryInquiry
250mg97%$204.00InquiryInquiry
1g97%$497.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-3,5-bis(3,4-dimethylphenyl)-1H-pyrazole
IUPAC Name4-bromo-3,5-bis(3,4-dimethylphenyl)-1H-pyrazole
MDL No.MFCD08552833
Molecular FormulaC19H19BrN2
Molecular Weight355.28
SMILESCC1=CC=C(C2=C(Br)C(C3=CC=C(C)C(C)=C3)=NN2)C=C1C
InChI KeyRVUBACGDNCNGFZ-UHFFFAOYSA-N
Synonym4-bromo-3,5-bis(3,4-dimethylphenyl)-1H-pyrazole;1H-Pyrazole, 4-bromo-3,5-bis(3,4-dimethylphenyl)-
CAS No.1187632-17-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPLCZ058 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWULS130 route compound structure diagram
    ACWULS13055499-43-9In Stock
  4. Then
  5. ACPLCZ058 route product structure diagram
    ACPLCZ0581187632-17-2
Inquiry

2. ACPLCZ058 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPLCZ058 route product structure diagram
    ACPLCZ0581187632-17-2
Inquiry

3. ACPLCZ058 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPLCZ058 route product structure diagram
    ACPLCZ0581187632-17-2
Inquiry

Comments (0)